<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34845562</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Long COVID from rheumatology perspective - a narrative review.</ArticleTitle><Pagination><StartPage>337</StartPage><EndPage>348</EndPage><MedlinePgn>337-348</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-021-06001-1</ELocationID><Abstract><AbstractText>Long-term sequel of acute COVID-19, commonly referred to as long COVID, has affected millions of patients worldwide. Long COVID patients display persistent or relapsing and remitting symptoms that include fatigue, breathlessness, cough, myalgia, arthralgia, sleep disturbance, cognitive impairment and skin rashes. Due to the shared clinical features, laboratory and imaging findings, long COVID could mimic rheumatic disease posing a diagnostic challenge. Our comprehensive literature review will help rheumatologist to be aware of long COVID manifestations and differentiating features from rheumatic diseases to ensure a timely and correct diagnosis is reached.</AbstractText><CopyrightInformation>&#xa9; 2021. International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sapkota</LastName><ForeName>Hem Raj</ForeName><Initials>HR</Initials><Identifier Source="ORCID">0000-0003-2314-2637</Identifier><AffiliationInfo><Affiliation>The Royal Wolverhampton Hospital NHS Trust, Wolverhampton, WV10 0QP, UK. Hem.sapkota@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nune</LastName><ForeName>Arvind</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3849-614X</Identifier><AffiliationInfo><Affiliation>Southport and Ormskirk NHS Trust, Southport, PR8 6PN, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012219" MajorTopicYN="Y">Rheumatology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Rheumatology</Keyword><Keyword MajorTopicYN="N">Systemic autoimmune rheumatic diseases</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34845562</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="doi">10.1007/s10067-021-06001-1</ArticleId><ArticleId IdType="pii">10.1007/s10067-021-06001-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Parums DV. Editorial: long COVID, or post-COVID syndrome, and the global impact on health care. Med Sci Monit. 2021;27:e933446. doi: 10.12659/MSM.933446.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933446</ArticleId><ArticleId IdType="pmc">PMC8194290</ArticleId><ArticleId IdType="pubmed">34092779</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS 2021 (Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 9/09/2021 access. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2september2021</Citation></Reference><Reference><Citation>Beeching NJ, Fletcher TE, Beadsworth MBJ. Covid-19: testing times. BMJ. 2020;369:m1403. doi: 10.1136/bmj.m1403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1403</ArticleId><ArticleId IdType="pubmed">32269032</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. 2021;18(5):2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence(NICE) (2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188] . Published Dec 2020. Available at (https://www.nice.org.uk/guidance/gid-ng10179/documents/final-scope) accessed 28/12/ 2020</Citation></Reference><Reference><Citation>World Health Organisation (WHO) (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Available at https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 Accessed 25/10/2021</Citation></Reference><Reference><Citation>Mahase E. Covid-19: two antibody tests are &#x201c;highly specific&#x201d; but vary in sensitivity, evaluations find. BMJ. 2020;369:m2066. doi: 10.1136/bmj.m2066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2066</ArticleId><ArticleId IdType="pubmed">32439655</ArticleId></ArticleIdList></Reference><Reference><Citation>Falahi S, Kenarkoohi A. COVID-19 reinfection: prolonged shedding or true reinfection? New Microbes New Infect. 2020;38:100812. doi: 10.1016/j.nmni.2020.100812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2020.100812</ArticleId><ArticleId IdType="pmc">PMC7657875</ArticleId><ArticleId IdType="pubmed">33200033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144. doi: 10.1186/s12913-020-06001-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C, Murray B, Varsavsky T, et al (2020) Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv 10.19.20214494; 10.1101/2020.10.19.20214494</Citation></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Preprint. medRxiv. 2021.01.27.21250617. Published 2021 Jan 30. 10.1101/2021.01.27.21250617</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;2020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M et al (2021) Post-COVID-19 symptoms 6&#xa0;months after acute infection among hospitalized and non-hospitalized patients [published online ahead of print, 2021 Jun 7]. Clin Microbiol Infect. S1198&#x2013;743X(21)00281&#x2013;0. 10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199(2):113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne) 2021;8:653516. doi: 10.3389/fmed.2021.653516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachoyiannopoulos PG, Magira E, Alexopoulos H, et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020;79:1661&#x2013;1663. doi: 10.1136/annrheumdis-2020-218009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218009</ArticleId><ArticleId IdType="pubmed">32581086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19) J Transl Autoimmun. 2020;3:100073. doi: 10.1016/j.jtauto.2020.100073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2020.100073</ArticleId><ArticleId IdType="pmc">PMC7691817</ArticleId><ArticleId IdType="pubmed">33263103</ArticleId></ArticleIdList></Reference><Reference><Citation>Litwin CM, Binder SR. ANA testing in the presence of acute and chronic infections. J Immunoassay Immunochem. 2016;37(5):439&#x2013;452. doi: 10.1080/15321819.2016.1174136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15321819.2016.1174136</ArticleId><ArticleId IdType="pubmed">27050929</ArticleId></ArticleIdList></Reference><Reference><Citation>Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, et al (2021) Onset of rheumatoid arthritis after COVID-19: coincidence or connected? [published online ahead of print, 2021 Mar 1].&#xa0;Ann Rheum Dis. annrheumdis-2021&#x2013;219859. 10.1136/annrheumdis-2021-219859</Citation><ArticleIdList><ArticleId IdType="pubmed">33648960</ArticleId></ArticleIdList></Reference><Reference><Citation>Callow KA, Parry HF, Sergeant M, Tyrrell DA. The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect. 1990;105(2):435&#x2013;446. doi: 10.1017/s0950268800048019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0950268800048019</ArticleId><ArticleId IdType="pmc">PMC2271881</ArticleId><ArticleId IdType="pubmed">2170159</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683. doi: 10.1016/j.eclinm.2020.100683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B, Liu Z, Tang L, et al. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. Int J Med Sci. 2021;18(1):29&#x2013;41. doi: 10.7150/ijms.49728.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.49728</ArticleId><ArticleId IdType="pmc">PMC7738960</ArticleId><ArticleId IdType="pubmed">33390771</ArticleId></ArticleIdList></Reference><Reference><Citation>Marvisi M, Ferrozzi F, Balzarini L, et al. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: factors predicting fibrotic evolution. Int J Infect Dis. 2020;99:485&#x2013;488. doi: 10.1016/j.ijid.2020.08.054).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.08.054)</ArticleId><ArticleId IdType="pmc">PMC7443096</ArticleId><ArticleId IdType="pubmed">32841688</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo YB, Lim YH, Kim KJ, Park KS, Park YJ. Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):199. doi: 10.1186/s13075-019-1977-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-1977-9</ArticleId><ArticleId IdType="pmc">PMC6716891</ArticleId><ArticleId IdType="pubmed">31470887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K, Kishimoto M, Shimasaki T, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020;6:e001350. doi: 10.1136/rmdopen-2020-001350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2020-001350</ArticleId><ArticleId IdType="pmc">PMC7722270</ArticleId><ArticleId IdType="pubmed">32763956</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol. 2021;40(8):3357&#x2013;3362. doi: 10.1007/s10067-020-05550-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05550-1</ArticleId><ArticleId IdType="pmc">PMC7882861</ArticleId><ArticleId IdType="pubmed">33587197</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;nge BL, Hermansen MF, Storgaard M. Reactive arthritis after COVID-19. BMJ Case Rep. 2021;14(3):e241375. doi: 10.1136/bcr-2020-241375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-241375</ArticleId><ArticleId IdType="pmc">PMC7929821</ArticleId><ArticleId IdType="pubmed">33653867</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al (2020) Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients [published online ahead of print, 2020 Nov 30]. Clin Infect Dis. ciaa1792. 10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Roongta R, Chattopadhyay A, Ghosh A (2021) Correspondence on &#x2018;Onset of rheumatoid arthritis after COVID-19: coincidence or connected?&#x2019; [published online ahead of print, 2021 Apr 27]. Ann Rheum Dis. annrheumdis-2021&#x2013;220479. 10.1136/annrheumdis-2021-220479</Citation><ArticleIdList><ArticleId IdType="pubmed">33906857</ArticleId></ArticleIdList></Reference><Reference><Citation>Batur EB, Korez MK, Gezer IA, Levendoglu F, Ural O. Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19. Int J Clin Pract. 2021;75(6):e14135. doi: 10.1111/ijcp.14135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14135</ArticleId><ArticleId IdType="pmc">PMC8250333</ArticleId><ArticleId IdType="pubmed">33686741</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Shan KS, Minalyan A, O&#x2019;Sullivan C, Nace T. A rare presentation of coronavirus disease 2019 (COVID-19) induced viral myositis with subsequent rhabdomyolysis. Cureus. 2020;12(5):e8074. doi: 10.7759/cureus.8074.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.8074</ArticleId><ArticleId IdType="pmc">PMC7290109</ArticleId><ArticleId IdType="pubmed">32542129</ArticleId></ArticleIdList></Reference><Reference><Citation>Beydon M, Chevalier K, Al Tabaa O, et al (2020) Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis 10.1136/annrheumdis-2020-217573. [Epub ahead of print: 23 Apr 2020].pmid:http://www.ncbi.nlm.nih.gov/pubmed/32327427</Citation><ArticleIdList><ArticleId IdType="pubmed">32327427</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Charmchi Z, Seidman RJ, et al (2020) COVID-19-associated myositis with severe proximal and bulbar weakness. Muscle Nerve 62:E57&#x2013;60.10.1002/mus.27003 pmid:http://www.ncbi.nlm.nih.gov/pubmed/32535934</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323133</ArticleId><ArticleId IdType="pubmed">32535934</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KH, Farouji I, Abu Hanoud A, Slim J. Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19) Am J Emerg Med. 2020;38(7):1548.e1&#x2013;1548.e3. doi: 10.1016/j.ajem.2020.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7211689</ArticleId><ArticleId IdType="pubmed">32414522</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Morales MD, Pell R, Rubero J, Ganti L. Acute myopericarditis in the post COVID-19 recovery phase. Cureus. 2020;12(10):e11247. doi: 10.7759/cureus.11247.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11247</ArticleId><ArticleId IdType="pmc">PMC7707144</ArticleId><ArticleId IdType="pubmed">33274129</ArticleId></ArticleIdList></Reference><Reference><Citation>Cares-Marambio K, Montenegro-Jim&#xe9;nez Y, et al. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Chron Respir Dis. 2021;18:14799731211002240. doi: 10.1177/14799731211002240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731211002240</ArticleId><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P et al (2021) Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clinical medicine (London, England) 21(1):e63&#x2013;e67. 10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Barratt SL, Condliffe R, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75:1009&#x2013;1016. doi: 10.1136/thoraxjnl-2020-215314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215314</ArticleId><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojha V, Mani A, Pandey NN, Sharma S, Kumar S. CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients. Eur Radiol. 2020;30(11):6129&#x2013;6138. doi: 10.1007/s00330-020-06975-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-06975-7</ArticleId><ArticleId IdType="pmc">PMC7261039</ArticleId><ArticleId IdType="pubmed">32474632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Dong C, Hu Y, et al. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology. 2020;296(2):E55&#x2013;E64. doi: 10.1148/radiol.2020200843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200843</ArticleId><ArticleId IdType="pmc">PMC7233482</ArticleId><ArticleId IdType="pubmed">32191587</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L, Khan A, Zhou W, et al. Follow-up study of clinical and chest CT scans in confirmed COVID-19 patients. Radiol Infect Dis. 2020;7(3):106&#x2013;113. doi: 10.1016/j.jrid.2020.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jrid.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7366983</ArticleId><ArticleId IdType="pubmed">32838006</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Charmchi Z, Seidman RJ, et al. COVID-19-associated myositis with severe proximal and bulbar weakness. Muscle Nerve. 2020;62(3):E57&#x2013;E60. doi: 10.1002/mus.27003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27003</ArticleId><ArticleId IdType="pmc">PMC7323133</ArticleId><ArticleId IdType="pubmed">32535934</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabaei SMH, Rajebi H, Moghaddas F, Ghasemiadl M, Talari H. Chest CT in COVID-19 pneumonia: what are the findings in mid-term follow-up? Emerg Radiol. 2020;27(6):711&#x2013;719. doi: 10.1007/s10140-020-01869-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10140-020-01869-z</ArticleId><ArticleId IdType="pmc">PMC7649573</ArticleId><ArticleId IdType="pubmed">33165674</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariano RZ, Rio APTD, Reis F. Covid-19 overlapping with systemic sclerosis. Rev Soc Bras Med Trop. 2020;53:e20200450. doi: 10.1590/0037-8682-0450-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0450-2020</ArticleId><ArticleId IdType="pmc">PMC7508197</ArticleId><ArticleId IdType="pubmed">32965452</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao M, Zhang S, Chu D, et al. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report. BMC Pulm Med. 2020;20(1):304. doi: 10.1186/s12890-020-01335-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-020-01335-z</ArticleId><ArticleId IdType="pmc">PMC7675391</ArticleId><ArticleId IdType="pubmed">33213393</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzberg LN, Advani S, Clancy DC, Lin A, Jorizzo JL. A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis. Skin Health Dis. 2021;1(2):e20. doi: 10.1002/ski2.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ski2.20</ArticleId><ArticleId IdType="pmc">PMC8250095</ArticleId><ArticleId IdType="pubmed">34235511</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, Gallman AE, Hruza GJ, et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021;21(3):313&#x2013;314. doi: 10.1016/S1473-3099(20)30986-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30986-5</ArticleId><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Killion L, Beatty PE, Salim A. Rare cutaneous manifestation of COVID-19. BMJ Case Rep. 2021;14(1):e240863. doi: 10.1136/bcr-2020-240863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-240863</ArticleId><ArticleId IdType="pmc">PMC10577745</ArticleId><ArticleId IdType="pubmed">33509895</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Bunker CB, Ciurtin C, et al. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect Dis. 2021;21(7):912. doi: 10.1016/S1473-3099(21)00133-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00133-X</ArticleId><ArticleId IdType="pmc">PMC8221732</ArticleId><ArticleId IdType="pubmed">33705725</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders HJ, Sigl T, Schattenkirchner M. Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis. 2001;60:407&#x2013;409. doi: 10.1136/ard.60.4.407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.60.4.407</ArticleId><ArticleId IdType="pmc">PMC1753600</ArticleId><ArticleId IdType="pubmed">11247874</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohabbat AB, Mohabbat NML, Wight EC. Fibromyalgia and chronic fatigue syndrome in the age of COVID-19. Mayo Clin Proc Innov Qual Outcomes. 2020;4(6):764&#x2013;766. doi: 10.1016/j.mayocpiqo.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7661943</ArticleId><ArticleId IdType="pubmed">33204998</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauw D, H&#xe4;user W, Cohen S, Fitzcharles M. Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. 2020;161(8):1694&#x2013;1697. doi: 10.1097/j.pain.0000000000001950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001950</ArticleId><ArticleId IdType="pmc">PMC7302093</ArticleId><ArticleId IdType="pubmed">32701829</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 2021;57(5):418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F, Ciaffi J, Mancarella L, et al. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021;7:e001735. doi: 10.1136/rmdopen-2021-001735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2021-001735</ArticleId><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 'long-haulers'? Chronic Dis Transl Med. 2021;7(1):14&#x2013;26. doi: 10.1016/j.cdtm.2020.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo JA, Mart&#xed;nez-L&#xf3;pez JP, Carrillo-Lamp&#xf3;n SA, et al. Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican cohort. Brain Sci. 2021;11(6):760. doi: 10.3390/brainsci11060760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11060760</ArticleId><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Grech S, Borg JN, Cuschieri S (2021) Back pain: An aftermath of Covid-19 pandemic? A Malta perspective [published online ahead of print, 2021 Jun 6]. Musculoskeletal Care. 10.1002/msc.1574.10.1002/msc.1574</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242888</ArticleId><ArticleId IdType="pubmed">34092018</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155&#x2013;162. doi: 10.1097/BOR.0000000000000776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2021;11:617089. doi: 10.3389/fimmu.2020.617089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.617089</ArticleId><ArticleId IdType="pmc">PMC7873987</ArticleId><ArticleId IdType="pubmed">33584709</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15(3):869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007)</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, et al. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31(3):365&#x2013;368. doi: 10.1007/s10286-021-00798-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ (Clinical research ed) 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad A, De Marco G, Mahajna H, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel) 2021;9(5):435. doi: 10.3390/vaccines9050435.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050435</ArticleId><ArticleId IdType="pmc">PMC8146571</ArticleId><ArticleId IdType="pubmed">33946748</ArticleId></ArticleIdList></Reference><Reference><Citation>Terracina KA, Tan FK. Flare of rheumatoid arthritis after COVID-19 vaccination. Lancet Rheumatol. 2021;3(7):e469&#x2013;e470. doi: 10.1016/S2665-9913(21)00108-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00108-9</ArticleId><ArticleId IdType="pmc">PMC8009616</ArticleId><ArticleId IdType="pubmed">33817664</ArticleId></ArticleIdList></Reference><Reference><Citation>Nune A, Iyengar KP, Ish P, Varupula B, Musat CA, Sapkota HR (2021) Emergence of new onset SLE following SARS-CoV-2 vaccination, QJM, hcab229, 10.1093/qjmed/hcab229</Citation><ArticleIdList><ArticleId IdType="pubmed">34450645</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>